Study of Mycobacterium w in Superficial Transitional Cell Carcinoma of Bladder

PHASE2CompletedINTERVENTIONAL
Enrollment

122

Participants

Timeline

Start Date

August 28, 2008

Primary Completion Date

March 31, 2014

Study Completion Date

October 7, 2015

Conditions
Bladder Cancer
Interventions
BIOLOGICAL

Mycobacterium w

Immunomodulator

BIOLOGICAL

BCG (Bacillus Calmette-Guerin)

Immunotherapeutic agent

Trial Locations (15)

110001

Dr. Ram Manohar Lohia Hospital & PGIMER, New Delhi

110029

V M Medical College & Safdarjang Hospital, New Delhi

141008

Christian Medical College, Ludhiana

160012

Post Graduate Institute of Medical Education and Research, Chandigarh

171001

Indira Gandhi Medical College, Shimla

334003

P.B.M. Hospital & A.G. of Hospitals, Bikaner

360002

Urocare Hospital, Rajkot

400012

Seth G S Medical College & K E M Hospital, Pārel

452014

Choithram Hospital and Research Centre, Indore

474009

Cancer Hospital and Research Institute, Gwalior

560090

N.R.R. Hospital, Bangalore

576104

Kasturba Medical college and Hospital, Manipal

682012

Lourdes Hospital, Kochi

700020

IPGMER, S.S.K.M. Hospital, Kolkata

Unknown

Muljibhai Patel Urological Hospital, Nadiād

Sponsors
All Listed Sponsors
lead

Cadila Pharnmaceuticals

INDUSTRY

NCT00694915 - Study of Mycobacterium w in Superficial Transitional Cell Carcinoma of Bladder | Biotech Hunter | Biotech Hunter